Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Hive Digital expands BUZZ HPC with new cluster in Quebec, acquires Toronto facility to fuel growth (Proactive Investors) +++ HIVE DIGITAL Aktie -3,44%

CHAMPIONS ONCOLOGY Aktie

 >Aktienkurs 
6.625 EUR    (Tradegate)
Ask: 6.8 EUR / 219 Stück
Bid: 6.45 EUR / 232 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
Aktie über LYNX handeln
>Performance
1 Woche: +2,6%
1 Monat: +34,8%
3 Monate: -24,7%
6 Monate: -12,7%
1 Jahr: +48,6%
laufendes Jahr: -14,1%
>CHAMPIONS ONCOLOGY Aktie
Name:  CHAMPIONS ONCOLOGY DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US15870P3073 / A14X6S
Symbol/ Ticker:  2I3 (Frankfurt) / CSBR (NASDAQ)
Kürzel:  FRA:2I3, ETR:2I3, 2I3:GR, NASDAQ:CSBR
Index:  -
Webseite:  https://www.championsonco..
Marktkapitalisierung:  83.18 Mio. EUR
Umsatz:  51.41 Mio. EUR
EBITDA:  7.4 Mio. EUR
Gewinn je Aktie:  0.342 EUR
Schulden:  5.65 Mio. EUR
Liquide Mittel:  2.81 Mio. EUR
Umsatz-/ Gewinnwachstum:  41.8% / -
KGV/ KGV lG:  14.25 / 22.32
KUV/ KBV/ PEG:  1.53 / 16.21 / -
Gewinnm./ Eigenkapitalr.:  10.97% / 376.84%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  CHAMPIONS ONCOLOGY
Letzte Datenerhebung:  24.06.25
>Eigentümer
Aktien: 13.83 Mio. St.
f.h. Aktien: 5.12 Mio. St.
Insider Eigner: 25.85%
Instit. Eigner: 49.28%
>Peer Group

 
28.04.25 - 16:18
 Champions Oncology, Inc.: Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House (Accesswire)
 
HACKENSACK, NJ / ACCESS Newswire / April 28, 2025 / Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in preclin......
24.04.25 - 14:18
 Champions Oncology, Inc.: Champions Oncology′s Data Platform Gains Momentum through a Strategic Collaboration with Turbine (Accesswire)
 
HACKENSACK, NJ / ACCESS Newswire / April 24, 2025 / Champions Oncology (NASDAQ:CSBR), a global leader in oncology R&D solutions, has announced a strategic collaboration with Turbine, the creators o......
11.03.25 - 21:06
 Champions Oncology, Inc.: Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million (Accesswire)
 
HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, t......
06.03.25 - 22:09
 Champions Oncology, Inc.: Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025 (Accesswire)
 
HACKENSACK, NJ / ACCESS Newswire / March 6, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, wi......
08.01.25 - 14:06
 Champions Oncology erweitert sein klinisch-bioanalytisches Leistungsportfolio mit neuer Technologie und zusätzlichem Führungsexperten (IRW Press)
 
HACKENSACK, NJ / ACCESSWIRE / 8. Januar 2025 / Champions Oncology, Inc. (NASDAQ: CSBR), eine führende technologiegestützte Organisation im Bereich der onkologischen Forschung, die spezielle......
08.01.25 - 14:03
 Champions Oncology, Inc.: Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership (Accesswire)
 
HACKENSACK, NJ / ACCESSWIRE / January 8, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading technology-enabled oncology research organization with specialty testing services, is excited to an......
12.12.24 - 04:33
 Stocks to Watch: Adobe, Champions Oncology, DBV Technologies (MarketWatch)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
12.12.24 - 03:57
 Champions Oncology Shares Rise on Higher 2Q Profit, Revenue (MarketWatch)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
11.12.24 - 23:30
 Recap: Champions Oncology Q2 Earnings (Benzinga)
 
read more...
11.12.24 - 22:46
 Champions Oncology Inc reports results for the quarter ended October 31 - Earnings Summary (Reuters EN)
 
Champions Oncology Inc reports results for the quarter ended October 31 - Earnings Summary Champions Oncology Inc CSBR.OQ reported quarterly adjusted earnings of 5 cents​​ per share for the quarter ended October 31, higher than the same quarter last year, when the company reported EPS of -15 cents. The lone analyst forecast for the quarter was for earnings of one cent per share....
11.12.24 - 22:12
 Champions Oncology Non-GAAP EPS of $0.05 beats by $0.04, revenue of $135.5M beats by $122.45M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.12.24 - 22:06
 Champions Oncology, Inc.: Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million (Accesswire)
 
HACKENSACK, NJ / ACCESSWIRE / December 11, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, tod......
05.12.24 - 22:43
 Champions Oncology, Inc.: Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024 (Accesswire)
 
HACKENSACK, NJ / ACCESSWIRE / December 5, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will......
12.09.24 - 21:00
 Champions Oncology upgraded to buy by Craig-Hallum (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.09.24 - 22:42
 Champions Oncology Non-GAAP EPS of $0.11 beats by $0.14, revenue of $14.06M beats by $0.83M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.09.24 - 22:08
 Champions Oncology, Inc.: Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million (Accesswire)
 
HACKSENSACK, NJ / ACCESSWIRE / September 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, t......
09.09.24 - 22:06
 Champions Oncology, Inc.: Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 (Accesswire)
 
HACKENSACK, NJ / ACCESSWIRE / September 9, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will repor......
22.07.24 - 23:19
 Champions Oncology Inc reports results for the quarter ended in April - Earnings Summary (Reuters EN)
 
Champions Oncology Inc reports results for the quarter ended in April - Earnings Summary...
18.07.24 - 22:54
 Champions Oncology Non-GAAP EPS of $0.01, revenue of $14M beats by $1.31M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Was man zu lang bedenkt, das wird bedenklich. - Sprichwort
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!